AIV Logo AIV Assistant

Loading...

 Logo Regencell Bioscience Holdings Limited Ordinary Shares - RGC Open Regencell Bioscience Holdings Limited Ordinary Shares in new tab

13.02 USD
EPS
-0.01
P/B
1189.29
ROE
-47.77
Beta
2.05

13.0200 USD

13.020 USD

Daily: -98.26%
Key Metrics

EPS: -0.01

Book Value: 0.01

Price to Book: 1189.29

Debt/Equity: 1.04

% Insiders: 96.155%

DCF Valuation

Tweak assumptions to recompute fair value for Regencell Bioscience Holdings Limited Ordinary Shares (RGC)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

 Logo About Regencell Bioscience Holdings Limited Ordinary Shares - (RGC)

Country: Hong Kong

Sector: Health Care

Website: nan

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Exchange Ticker
NMS (United States) RGC
Historical Dividends
Year Total Dividends
2018 8.36 USD
2017 33.44 USD
2016 33.44 USD
2015 33.44 USD
2014 33.44 USD
2013 31.92 USD
2012 31.92 USD
2011 31.92 USD
2010 27.36 USD
2009 20.52 USD

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion